Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-18

Clinical Trial Update: The Clinical Study on the Treatment of SSc With UTAA91 Injection. [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating UTAA91 injections for systemic sclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • UTAA91

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Systemic Sclerosis (SSc) | EARLY_Phase 1 | Status: RECRUITING